Report Detail
Global MRSA Drugs Market Insights, Forecast to 2025
- RnM3539360 |
- 19 June, 2019 |
- Global |
- 129 Pages |
- QYResearch |
- Pharma & Healthcare
Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called methicillin. MRSA strains do not respond to methicillin treatment. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA. The infection causes skin and tissue infection, and is transmitted by direct skin-to-skin contact.
Methicillin-resistant Staphylococcus aureus (MRSA) is a skin infection that occurs mostly in hospitals and healthcare facilities. It is treated with commonly-used antibiotics and is highly contagious. This infection is difficult to treat because it is sometimes resistant to commonly-used antibiotics such as methicillin. As per this market research report, the aging people are highly susceptible to MRSA infections, especially in the hospital environment as their weak immune system makes them easily prone to diseases and infections.
The global MRSA Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the MRSA Drugs market based on company, product type, end user and key regions.
This report studies the global market size of MRSA Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of MRSA Drugs in these regions.
This research report categorizes the global MRSA Drugs market by top players/brands, region, type and end user. This report also studies the global MRSA Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Allergan
Merck
Pfizer
Theravance Biopharma
Absynth Biologics
AmpliPhi Biosciences
AstraZeneca
Basilea Pharmaceutica
Baxter
Cellceutix
Cempra
CrystalGenomics
Debiopharm
Galapagos
GSK
KYORIN Pharmaceutical
Lytix Biopharma
Melinta Therapeutics
Nabriva Therapeutics
NovaDigm Therapeutics
Market size by Product
Tetracycline
Folate antagonist
Cephalosporin
Lipopeptides
Oxazolidinone
Lipoglycopeptide
Market size by End User
Hospital
Research
Clinic
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global MRSA Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of MRSA Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global MRSA Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of MRSA Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of MRSA Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of MRSA Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 MRSA Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global MRSA Drugs Market Size Growth Rate by Product
- 1.4.2 Tetracycline
- 1.4.3 Folate antagonist
- 1.4.4 Cephalosporin
- 1.4.5 Lipopeptides
- 1.4.6 Oxazolidinone
- 1.4.7 Lipoglycopeptide
- 1.5 Market by End User
- 1.5.1 Global MRSA Drugs Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Research
- 1.5.4 Clinic
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global MRSA Drugs Market Size
- 2.1.1 Global MRSA Drugs Revenue 2014-2025
- 2.1.2 Global MRSA Drugs Sales 2014-2025
- 2.2 MRSA Drugs Growth Rate by Regions
- 2.2.1 Global MRSA Drugs Sales by Regions
- 2.2.2 Global MRSA Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 MRSA Drugs Sales by Manufacturers
- 3.1.1 MRSA Drugs Sales by Manufacturers
- 3.1.2 MRSA Drugs Sales Market Share by Manufacturers
- 3.1.3 Global MRSA Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 MRSA Drugs Revenue by Manufacturers
- 3.2.1 MRSA Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 MRSA Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 MRSA Drugs Price by Manufacturers
- 3.4 MRSA Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 MRSA Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers MRSA Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into MRSA Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global MRSA Drugs Sales by Product
- 4.2 Global MRSA Drugs Revenue by Product
- 4.3 MRSA Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global MRSA Drugs Breakdown Data by End User
6 North America
- 6.1 North America MRSA Drugs by Countries
- 6.1.1 North America MRSA Drugs Sales by Countries
- 6.1.2 North America MRSA Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America MRSA Drugs by Product
- 6.3 North America MRSA Drugs by End User
7 Europe
- 7.1 Europe MRSA Drugs by Countries
- 7.1.1 Europe MRSA Drugs Sales by Countries
- 7.1.2 Europe MRSA Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe MRSA Drugs by Product
- 7.3 Europe MRSA Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific MRSA Drugs by Countries
- 8.1.1 Asia Pacific MRSA Drugs Sales by Countries
- 8.1.2 Asia Pacific MRSA Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific MRSA Drugs by Product
- 8.3 Asia Pacific MRSA Drugs by End User
9 Central & South America
- 9.1 Central & South America MRSA Drugs by Countries
- 9.1.1 Central & South America MRSA Drugs Sales by Countries
- 9.1.2 Central & South America MRSA Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America MRSA Drugs by Product
- 9.3 Central & South America MRSA Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa MRSA Drugs by Countries
- 10.1.1 Middle East and Africa MRSA Drugs Sales by Countries
- 10.1.2 Middle East and Africa MRSA Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa MRSA Drugs by Product
- 10.3 Middle East and Africa MRSA Drugs by End User
11 Company Profiles
- 11.1 Allergan
- 11.1.1 Allergan Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Allergan MRSA Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Allergan MRSA Drugs Products Offered
- 11.1.5 Allergan Recent Development
- 11.2 Merck
- 11.2.1 Merck Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck MRSA Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck MRSA Drugs Products Offered
- 11.2.5 Merck Recent Development
- 11.3 Pfizer
- 11.3.1 Pfizer Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Pfizer MRSA Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Pfizer MRSA Drugs Products Offered
- 11.3.5 Pfizer Recent Development
- 11.4 Theravance Biopharma
- 11.4.1 Theravance Biopharma Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Theravance Biopharma MRSA Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Theravance Biopharma MRSA Drugs Products Offered
- 11.4.5 Theravance Biopharma Recent Development
- 11.5 Absynth Biologics
- 11.5.1 Absynth Biologics Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Absynth Biologics MRSA Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Absynth Biologics MRSA Drugs Products Offered
- 11.5.5 Absynth Biologics Recent Development
- 11.6 AmpliPhi Biosciences
- 11.6.1 AmpliPhi Biosciences Company Details
- 11.6.2 Company Business Overview
- 11.6.3 AmpliPhi Biosciences MRSA Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 AmpliPhi Biosciences MRSA Drugs Products Offered
- 11.6.5 AmpliPhi Biosciences Recent Development
- 11.7 AstraZeneca
- 11.7.1 AstraZeneca Company Details
- 11.7.2 Company Business Overview
- 11.7.3 AstraZeneca MRSA Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 AstraZeneca MRSA Drugs Products Offered
- 11.7.5 AstraZeneca Recent Development
- 11.8 Basilea Pharmaceutica
- 11.8.1 Basilea Pharmaceutica Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Basilea Pharmaceutica MRSA Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Basilea Pharmaceutica MRSA Drugs Products Offered
- 11.8.5 Basilea Pharmaceutica Recent Development
- 11.9 Baxter
- 11.9.1 Baxter Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Baxter MRSA Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Baxter MRSA Drugs Products Offered
- 11.9.5 Baxter Recent Development
- 11.10 Cellceutix
- 11.10.1 Cellceutix Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Cellceutix MRSA Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Cellceutix MRSA Drugs Products Offered
- 11.10.5 Cellceutix Recent Development
- 11.11 Cempra
- 11.12 CrystalGenomics
- 11.13 Debiopharm
- 11.14 Galapagos
- 11.15 GSK
- 11.16 KYORIN Pharmaceutical
- 11.17 Lytix Biopharma
- 11.18 Melinta Therapeutics
- 11.19 Nabriva Therapeutics
- 11.20 NovaDigm Therapeutics
12 Future Forecast
- 12.1 MRSA Drugs Market Forecast by Regions
- 12.1.1 Global MRSA Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global MRSA Drugs Revenue Forecast by Regions 2019-2025
- 12.2 MRSA Drugs Market Forecast by Product
- 12.2.1 Global MRSA Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global MRSA Drugs Revenue Forecast by Product 2019-2025
- 12.3 MRSA Drugs Market Forecast by End User
- 12.4 North America MRSA Drugs Forecast
- 12.5 Europe MRSA Drugs Forecast
- 12.6 Asia Pacific MRSA Drugs Forecast
- 12.7 Central & South America MRSA Drugs Forecast
- 12.8 Middle East and Africa MRSA Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 MRSA Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on MRSA Drugs . Industry analysis & Market Report on MRSA Drugs is a syndicated market report, published as Global MRSA Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of MRSA Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
